Edwards Lifesciences (NYSE:EW) traded lower in the premarket on Thursday after Wolfe Research downgraded the heart device ...
Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...
Edwards Lifesciences Corp. engages in the patient ... Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart and Critical Care. The Transcatheter ...
The US Supreme Court rejected a case asking the justices to interpret a patent-infringement safe-harbor provision in a ...
Wedgewood Partners, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the letter ...
The transcatheter heart valve (THV) is designed to replace ... Larry Wood, vice president at Edwards Lifesciences, said: “These strong, real-world data continue to demonstrate that patients ...
Hosted on MSN9d
Edwards Lifesciences’ Q4 2024 Earnings: What to ExpectEdwards Lifesciences Corporation (EW), headquartered in Irvine, California, is a company that specializes in innovative ...
Zacks Research raised their FY2024 earnings per share (EPS) estimates for Edwards Lifesciences in a research note issued on ...
Citi analyst Joanne Wuensch maintained a Buy rating on Edwards Lifesciences (EW – Research Report) today. The company’s shares closed yesterday ...
In a report released yesterday, Lee Hambright from Bernstein maintained a Hold rating on Edwards Lifesciences (EW – Research Report). The ...
Edwards Lifesciences Corporation (EW), headquartered ... the company offers products such as tissue replacement heart valves, heart valve repair, hemodynamic monitoring devices, angioscopy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback